This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Lincoln National Q3 Earnings Beat on Strong Premiums, High Costs Ail
by Zacks Equity Research
LNC's Q3 results benefit from strong insurance premiums and a well-performing Group Protection segment. However, elevated expenses and lower investment income affect results.
American Financial Q3 Earnings Miss on Higher Catastrophe Losses
by Zacks Equity Research
AFG's Q3 results reflect higher premiums, increased average renewal pricing and improved net investment income, offset by higher expenses and catastrophe losses.
Are Finance Stocks Lagging Interactive Brokers (IBKR) This Year?
by Zacks Equity Research
Here is how Interactive Brokers Group, Inc. (IBKR) and Axis Capital (AXS) have performed compared to their sector so far this year.
AXS vs. CINF: Which Stock Is the Better Value Option?
by Zacks Equity Research
AXS vs. CINF: Which Stock Is the Better Value Option?
Are Investors Undervaluing Axis Capital Holdings (AXS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AXIS Capital Q3 Earnings and Revenues Beat, Premiums Rise Y/Y
by Zacks Equity Research
AXS' third-quarter results reflect improved net investment income and higher premiums, offset by poor underwriting income.
Axis Capital (AXS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Axis Capital (AXS) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Axis Capital (AXS) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Axis Capital (AXS) delivered earnings and revenue surprises of 8.40% and 0.40%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Q3 Showdown: Can These 5 Insurance Stocks Beat the Estimates?
by Kaibalya Pravo Dey
Increasing rates, underwriting practices and other factors are expected to have benefited insurance players in the third quarter. AFL, MET, ALL, PRU & AXS will release earnings on Oct. 30.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Berkshire Hathaway B (BRK.B) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Berkshire Hathaway B (BRK.B) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should AXS Stock Be in Your Portfolio Ahead of Q3 Earnings?
by Tanuka De
Axis Capital's third-quarter results are likely to gain from solid performance at both the segments.
Can Arch Capital Retain Its Beat Streak This Earnings Season?
by Zacks Equity Research
ACGL's Q3 results are likely to reflect new business opportunities, growth in existing accounts and a rise in invested assets, partly offset by higher expenses.
Axis Capital (AXS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Axis Capital (AXS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Chubb Limited Retain its Beat Streak This Earnings Season?
by Zacks Equity Research
CB's third-quarter results are likely to reflect higher premiums, driven by rate and exposure increases, and solid new business.
Is a Beat in the Cards for Cincinnati Financial in Q3 Earnings?
by Zacks Equity Research
CINF's Q3 results are likely to reflect rate increases, higher policy retention rates and higher bond yields, offset by a higher expense.
AXS Stock Trades at a Discount to Industry: Should You Buy or Hold?
by Tanuka De
Axis Capital continues to build on specialty insurance, reinsurance as well as the accident and health portfolio.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Will Axis Capital (AXS) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Axis Capital (AXS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Axis Capital (AXS) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks.com featured highlights include JD.com, EnerSys, AXIS Capital and Pebblebrook Hotel
by Zacks Equity Research
JD.com, EnerSys, AXIS Capital and Pebblebrook Hotel have been highlighted in this Screen of The Week article.
4 Top Value Stocks to Invest In as the Market Faces Volatility
by Sumit Singh
Value investing is essentially about selecting stocks that are cheap but fundamentally sound. JD, ENS, AXS & PEB boast a low P/CF ratio.
Travelers Rises 38.5% in a Year: Can the Stock Retain the Bull Run?
by Zacks Equity Research
TRV stock rallies on the back of a strong renewal rate change, retention and increase in new business supported by a compelling portfolio and solid capital position.
RLI Estimates Q3 Catastrophe Loss of $35M to $40M From Hurricanes
by Zacks Equity Research
Catastrophe losses from Hurricanes Beryl and Helene are likely to be reflected in RLI's third-quarter results.